Introduction 

Dealmakers are operating against a background of acute geopolitical and macroeconomic volatility.

The impact has been sharpened by ongoing conflict, political instability, regulatory fragmentation and shifting trade and investment dynamics.  The economic ramifications – from volatility in energy and commodity markets to inflationary pressures and disruption to trade flows – add significant complexity to M&A planning and execution.

These shifting dynamics are making it increasingly harder for deals to get done, as risk appetites are reined in and uncertainty weighs on confidence.

Adapting to a “new normal”

This environment is undoubtedly more acute – and unpredictable - than in the recent past, however it is no longer unprecedented.  Businesses have shown remarkable adaptability in responding to successive waves of disruption over the last decade.  Deal activity has proven robust through these cycles despite the challenges, with dealmakers becoming accustomed to sustained uncertainty in what has come to be seen as a “new normal”.

Whilst uncertainty can weigh on deal activity, it also presents opportunity to those with the resilience and conviction to move ahead – and transactions are continuing where there are strategic or commercial imperatives to execute.

In such cases, uncertainty and volatility is making deals more complex and challenging to deliver, requiring greater focus on execution risk, timing and structure.  Dealmakers are showing increasing resilience in this regard, adjusting to sustained uncertainty as a feature of the landscape and deploying creativity and discipline to navigate it.

Dealmaking through volatility

In this latest edition of our Strategic M&A series, we look at how dealmaking is responding to these challenges. 

Drawing on our depth of experience, we examine the recurring themes and share practical steps that dealmakers are using to continue to execute on strategic M&A and get deals done in an increasingly uncertain environment. 

Key takeaways

  1. Bridging valuation gaps is key, with a range of pricing structures being used to get deals done.
  2. Deal certainty matters more than ever, which is focusing minds on more considered risk allocation in the face of increasing regulatory scrutiny.
  3. Successful dealmaking amid uncertainty requires resilience, creativity and discipline.


"Uncertainty and volatility is making deals more challenging to deliver, requiring greater focus on execution risk, timing and structure”

Valuation gaps: How are buyers and sellers bridging the gap on price?

Bridge mechanisms

Price continues to be the most fundamental aspect of M&A transactions that is impacted by wider geopolitical and macroeconomic uncertainty.

Valuations are acutely vulnerable to the unpredictability of geopolitical and macroeconomic events, as commercial teams and financial advisers contend modelling the impact on projected performance and sustainability of a business over the longer term.

As uncertainty rises, parties inevitably prioritise risk avoidance and focus on downside protection.  At the same time, this can lead to a flight to quality and greater competition for the best opportunities, driving up average deal values for fewer prized assets.

Against this backdrop, dealmakers are increasingly relying on the full range of “bridge mechanisms” to close the gap and get the deal done - whether by altering risk profiles, mitigating exposure to downside risks, or linking payments to future performance.

In this section, we explore the most prevalent bridge mechanisms that are being utilised in M&A transactions to close the price gap, and share practical steps that dealmakers are using to get deals across the line.

Earn-outs

Earn-outs involve part of the purchase price being calculated by reference to the target’s post-acquisition performance.  They are used to bridge valuation gaps where parties’ views and expectations differ on future earnings, allowing consideration to adjust based on actual performance and thus facilitating risk‑sharing between the buyer and seller.

Earn‑outs are particularly relevant where uncertainty affects the target’s future earnings profile, including where:

  • the target operates in a sector or has an industrial base that is particularly sensitive to geopolitical or macroeconomic factors (e.g. tariffs, trade measures, supply chain disruption or commodity price volatility); and/or
  • earnings have been adversely affected by such factors or vulnerabilities exposed, without certainty as to whether the impact will prove to be temporary or structural.

Practical considerations

  • Well-prepared parties will assess the feasibility of an earn-out early in the process, including to determine whether suitable performance metrics (whether financial or operational) can be measured objectively in light of the business and the buyer’s plans for it after completion.
  • Earn-outs can result in disputes if not thoughtfully structured and clearly drafted.  Every earn-out, and the parameters that underpin it, is unique to the target business.
  • Engage accounting and tax specialists from the outset to ensure metrics are workable and the intended tax treatment can be achieved.  If the earn-out is to be based on specially prepared earn-out accounts and an underlying reward formula (rather than annual accounts), specific accounting policies may also be required.
  • Sellers should seek robust conduct protections to prevent artificial manipulation of performance metrics, including ordinary‑course obligations and arm’s‑length dealing requirements.  It may also be appropriate to consider security for the earn-out. Clear dispute resolutions procedures will be required.
  • Earn‑outs are commonly structured over one to three financial years post‑completion, to balance alignment of interests with the need for certainty.  The earn-out payment could be a single fixed payment at the end of the period or multiple, incremental payments.

Deferred consideration and vendor financing

Deferred consideration

Deferred consideration involves the seller agreeing to receive part of the purchase price at one or more specified dates following completion, rather than the entirety of the purchase price being paid in cash at completion. 

Unlike an earn-out, the deferred amounts are typically fixed and not contingent on post-completion performance, providing greater certainty to both parties on the amount, whilst still allowing the buyer to defer its cash outlay.  Deferred consideration is used to bridge valuation gaps where buyers are unwilling or unable to commit the full purchase price upfront, but where the parties are sufficiently aligned on headline valuation.

From a buyer's perspective, deferred consideration reduces the immediate funding requirement, can ease pressure on acquisition financing and allows the buyer to use the target's own cash generation to fund subsequent instalments.  For sellers, the structure preserves headline deal value and avoids the uncertainty inherent in performance-based mechanisms, though it introduces credit risk on the buyer and delays receipt of full proceeds.

Vendor financing

Vendor financing goes further, with the seller agreeing to lend part of the purchase price to the buyer, typically through subordinated loan notes or other debt-like instruments. This offers sellers enhanced credit protection through subordination terms, security and defined repayment schedules.

For a buyer, vendor financing can provide greater flexibility in structuring acquisition financing, particularly where third-party debt markets are constrained or where lenders require the seller to retain economic exposure as a condition of providing acquisition finance.

That said, vendor financing introduces additional complexity - including intercreditor considerations and the need to align with the buyer's external financing arrangements - which may not be warranted where the deferred consideration is modest or the credit risk is low.

Practical considerations

  • There is significant flexibility in the terms of both deferred consideration and vendor financing arrangements, but careful and early planning to optimise for tax and accounting outcomes is key.
  • Sellers typically focus on credit protection, including (in the case of vendor financing) subordination terms, security, interest rates and clear repayment profiles.  If payment of deferred consideration is conditional on certain outcomes (such as financial performance targets), the conditions and consequences will need to be clearly drafted.
  • Buyers should ensure that the terms of any deferred consideration or vendor financing align with their external financing constraints, including intercreditor arrangements and covenant packages. 
  • Both structures are more commonly deployed in bilateral or less competitive processes.  In an auction process, a proposal that relies on deferred consideration or vendor financing may signal limited alternative funding options and could put the bidder at a disadvantage.

Rollovers and structured equity

Whilst not a novel structure, there has been an increase in deals where a rollover is used to help bridge a valuation gap.  Rollovers involve a portion of the consideration for a sale being reinvested into the purchaser’s equity structure rather than being paid out to the seller directly in cash.

From a buyer’s perspective, this reduces the size of the upfront equity cheque (typically, whilst still acquiring control) and requires the seller to stand behind the business plan going forward, ensuring it has ‘skin in the game’ and better aligning interests on future performance – a particularly important feature on carve-out transactions.  It also demonstrates seller confidence in the business and allows sellers to retain upside exposure, which can be appealing where there is anticipated growth.

Practical considerations

A roll-over adds significant complexity to deal structure, as it introduces a retained shareholding in the business after completion – and requires negotiation of a shareholders’ agreement between buyer and seller.

If a rollover structure is contemplated, early thought to the terms of future shareholding arrangements will be important to avoid losing pace in a competitive auction process.  A term sheet is typically agreed in advance, and key considerations include:

  • governance and control rights, including any board seats and the scope of seller influence over strategic commercial matters;
  • minority protections, typically focused on economic rights such as right to receive distributions and veto rights over changes to capital structure;
  • liquidity and exit rights, such as the timing and structure of an exit, ability to sell to third parties and who controls any sales process; and
  • information and audit rights in relation to the target business, which will be particularly important where the seller is a listed company.

 

Structured equity

Deals can also incorporate differentiated equity structures – including ordinary, preferred and subordinated equity tranches – as a bridging mechanism.  These structures allows parties to tailor the economics of a transaction by allocating risk and return disproportionately.

Commonly used in private equity transactions to ensure sponsors secure downside protection and priority returns over management teams, these are increasingly being seen as part of the toolkit for bridging a valuation gap on M&A transactions, where a seller is asked to retain exposure but seeks protection against downside risk or delayed liquidity.

Under these structures, one or more shareholders receive priority distributions (often capped at an agreed threshold) before ordinary equity participates, altering the risk‑return profile of the future investment rather than the ‘Day 1’ valuation or the amount of equity retained.

Deal certainty and conditionality: Alongside valuation, deal certainty remains the top priority


In the face of a more uncertain deal environment, execution certainty has become critical alongside price. Buyers and sellers are sharpening their focus on risk allocation around regulatory approvals, financing and interim protections, while pursuing disciplined and front‑loaded deal processes to manage extended timelines and complexity.

Navigating regulatory uncertainty

While regulatory risk in M&A is most acute for “strategic” assets (such as defence, infrastructure, data or critical minerals) and in cases involving newer antitrust theories of harm (such as the entrenchment of a dominant position), heightened and evolving regulatory scrutiny is now affecting deals across the full range of industries, increasing uncertainty around execution and timing. Regulatory enforcement is adapting to fluctuating political imperatives and policy goals, with greater interventionism and a focus on FDI now often forming the backdrop for deals.

Spotlight on UK public M&A

Conditionality is approached differently in public takeovers, in light of Rule 13 of the Takeover Code and its “material significance test” for invoking conditions.

However, bidders and targets are increasingly focused on strategies to reduce overall deal timeline.

These include “starting the clock” on filings as quickly as possible, as well as shortening timescales once “on the clock” through early engagement with regulators.

 

Mandatory vs voluntary approvals

Sellers are placing greater focus on the list of regulatory deal conditions, with a particular attention on any voluntary approvals, alongside deep and early upfront regulatory risk analysis, especially on auctions.  Bidders, on the other hand, are increasingly considering whether they can sign transactions without conditionality for clearances under voluntary regimes, in order to make their bid more attractive.

As regulatory regimes proliferate globally, parties are also closely negotiating whether failure to secure approvals that would not have a material adverse effect on the bidder should be permitted as conditions to completion.

Sweeper conditions

The inclusion and scope of sweeper conditions (which allow the bidder to add conditions for regulatory approvals between signing and completion) are under sharper focus. Sweeper conditions protect buyers against change-in-law risk and a regulator inviting a filing post-signing. However, sellers will resist an unfettered sweeper, which, in the worst case, could result in late additions of conditions timing out a transaction or the buyer invoking an additional condition in the event it is unsatisfied. 

If agreed, parties will consider whether:

  • additions should be limited to mandatory regimes or inclusive of  voluntary ones too;
  • conditions to invoking a sweeper should be included (e.g. material adverse effect on the bidder) and if these should differ between approvals.

Delays and long stop dates

On more complex, multi-jurisdictional deals, counterparties are increasingly open to the need for extended long stop dates, typically around 18-24 months. Where regulatory conditions prove more time consuming than expected, parties may need to re-negotiate the timing of the long stop date, however this risks giving counterparties the opportunity to also re-open other deal terms.

Financial terms are increasingly being used to incentivise the bidder to close as soon as possible and compensate the seller for delays – these include “ticking fees” or permitted dividend regimes that step up if completion does not occur by a certain date.

Reverse break frees

There has been an increase in the number and value of reverse break fees (RBFs) in deals with greater risk of regulatory scrutiny.

RBFs create a strong incentive for the buyer to take the necessary steps to obtain regulatory approvals, whilst also compensating the seller for deal risk if the transaction collapses for regulatory reasons.

Trends and practice points

The fee amounts are often tiered based on the triggering event. For example, in a public M&A context, failure to satisfy regulatory conditions may have a higher fee than a failed bidder shareholder vote (unless a failed vote follows the target board withdrawing its recommendation, which is likely to be the highest fee trigger).

Fees are typically set at a level that is material enough to incentivise the buyer, often 2-4% of deal value – although this varies depending on the level of perceived regulatory risk and type of trigger event.

RBFs should be negotiated in the round with the bidder’s overall standard of endeavour to satisfy conditions.  Where parties are apart on the level of commitment (e.g. best endeavours vs hell or high water) or the scope of any qualifications (e.g. excluding certain divestment remedies), an RBF may form part of an overall acceptable package – although a seller will seek to ensure the fee is payable regardless of the level of effort the buyer has expended.

MAC conditions

While still less prevalent in the UK than in the US, there has been some resurgence in the use of material adverse change (MAC) clauses as a risk allocation tool in private M&A transactions – reflecting increased influence from the US market on EMEA deals.

However, it remains less common in the UK market and, unless the buyer has strong bargaining power, sellers will generally resist giving the buyer a walk-away right – particularly where the regulatory risk is a function of the identity of the buyer.

Trends and practice points

Where MACs are included, they should contain bespoke triggers that are tailored to target- or sector-specific risks, rather than general qualitative triggers.

Where macro-level carve outs are included (such as conflict, inflationary impact) a proportionality “kick-back” will often be negotiated to capture changes that adversely affect the target in a disproportionate way relative to other companies in the same sector.  This works to limit the carve-outs, and key negotiation points might include how to define the peer group to which performance will be compared, and to which carve-outs the limitation should apply.

MACs can be framed as a termination event (allowing the buyer to walkaway at any time when there is a MAC) in which case, notification and remedy provisions need careful thought. Alternatively, “no MAC having occurred” could be a condition to completion, which tends to allow time for transitory or short-term effects to pass.

Sellers who accept its inclusion should stress-test the applicability of a MAC with in-house commercial teams, to ascertain if the proposed formulation is appropriate and set at a standard that is high enough for the business to tolerate. 

Interim covenants

Another feature of deals with protracted sign-to-close timelines is greater attention on interim period covenants.  Adequate conduct of business protections remain critical for buyers in preserving deal value between signing and closing by restricting the seller’s ability to take (or omit from taking) material actions without the buyer’s consent, such as incurring capital expenditure, doing M&A, and entering into or amending material contracts.

Trends and practice points

Negotiations are focusing on greater specificity, with clearer compliance standards, defined consent thresholds and tailored carve-outs – whilst also ensuring the seller has sufficient flexibility to run its business normally and without raising ‘gun-jumping’ concerns prior to regulatory approvals.

Buyer rights to audit seller compliance with agreed covenants are also an emerging feature of negotiations where the interim period is lengthy – although UK practice is not as buyer-friendly as the US, where a completion condition that requires there to have been no material breach of interim covenants remains a common feature of US deals.

Conduct of business provisions should be read alongside, and made to work with, any specific policies or leakage covenants agreed on deals with completion accounts or a locked box.

User-friendly crib sheets (or “do’s and don’ts”) that can be circulated to the wider business and commercial teams are often a useful way to ensure that seller and target obligations and restrictions remain on the radar of appropriate personnel internally for the full length of the interim period.

Bidder financing

With the extended period of lower interest rates behind us, there have been cases of increased pressure on bidder financing, particularly where finance is committed for potentially lengthy sign-to-close periods.

Trends and practice points

Banks have generally shown reduced appetite for larger deals, and less willingness to lend on balance sheet without clear syndication routes.  Private credit has increasingly stepped up as an alternative source of bidder finance and now competes directly with banks, sometimes joining together to finance larger transactions.

Short-term bridge facilities remain common, offering quick negotiation for certain funds purposes and typically refinanced rapidly, usually before completion.  Longer-term acquisition debt has declined, though is still seen on certain transactions, offering upfront funding certainty.

The type and scope of commitment letters to be given at signing, and restrictions on amendments to financing terms are likely to be a focus of negotiations, alongside the level of cooperation the seller is required to give to the buyer to enable it to secure its financing (such a providing information for marketing and syndication purposes).  

Confidentiality and disclosure provisions will need to work alongside financing proposals and there is often a tension between them that needs to be balanced.

Finance conditionality (or “financing-outs”) remains a US concept and less commonly seen in the UK, but there have been deals where it has been accepted with a RBF to compensate the seller for financing risk.

 

Recent experience

A selection of our recent transactional experience across a range of strategic acquisitions, divestments and carve-outs.

  • Reckitt on the divestment of its Essential Home business to Advent International Limited for US $4.8bn
  • Global Infrastructure Partners (a part of BlackRock) on its creation of a 50:50 joint venture with ACS Group dedicated to developing and operating next-generation data centres worldwide
  • Greencore on its recommended acquisition of Bakkavor for £1.2bn
  • Senior on the sale of its Aerostructures business to Sullivan Street Partners
  • NatWest on its acquisition of Evelyn Partners from funds advised by Permira and Warburg Pincus for £2.7bn
  • Johnson Matthey on the sale of its Catalyst Technologies business to Honeywell for £1.8bn and on the sale of its Medical Device Components to Montau Private Equity for US $700mn
  • Alliance on the carve out and subsequent disposal of its pharmaceutical division to two unrelated UK pharmaceutical companies
  • INEOS on the sale of its Composites business to KPS Capital Partners
  • GlobalPayments on its acquisition of Worldpay from FIS and GTCR and the divestment of its Issuer Solutions business to FIS for US $13.5bn
  • CPP Investments and Equinix on their joint acquisition of atNorth from Partners Group for US $4bn
  • Morgan Advanced Materials on the sale of its global Molten Metals Systems business to Vesuvius plc
  • IDS (formerly Royal Mail) on its recommended acquisition by EP Group for £3.5bn
  • Reinet, CVC, ADIA and HPS on the sale of their shareholdings in Pension Insurance Corporation Limited to Athora Holding UK Limited for £5.7bn
  • Wilson Sons and Ultranav on the all-cash disposal of their respective joint venture interests in Wilson, Sons Ultratug Participações S.A. and Atlantic Offshore Services S.A. for US $500mn
  • Bunzl on its acquisition of an 80% stake in Nisbets Limited and associated entities
  • Diageo on the sale of its 65% shareholding in East African Breweries plc and its 53.68% interest in UDV Limited to Asahi Group Holdings